Insmed (INSM) Capital Expenditures (2011 - 2026)

Insmed's Capital Expenditures history runs 16 years deep, the most recent figure standing at $3.5 million for Q1 2026.

• On a quarterly basis, Capital Expenditures fell 65.44% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was -$4.5 million, a 316.01% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, up 125.47% from the prior year.
• Capital Expenditures slipped to $3.5 million in Q1 2026 per INSM's latest filing, from $11.8 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $11.8 million in Q4 2025 and bottomed at -$23.2 million in Q3 2025.
• The 5-year median for Capital Expenditures is $3.4 million (2023), against an average of $1.2 million.
• Across the five-year window, Capital Expenditures slumped 478.47% in 2024 and jumped 3124.02% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at -$3.1 million in 2022, then jumped by 168.46% to $2.2 million in 2023, then tumbled by 225.87% to -$2.7 million in 2024, then jumped by 534.94% to $11.8 million in 2025, then slumped by 70.48% to $3.5 million in 2026.
• Per Business Quant, the three latest INSM Capital Expenditures figures stand at $3.5 million (Q1 2026), $11.8 million (Q4 2025), and -$23.2 million (Q3 2025).